LT
Lisata Therapeutics Inc.
🇺🇸XNAS.LSTAUnited StatesHealthcare
$1.51USDdown -0.05 (-3.21%)OpenEnd of day5:40 PM
Price$1.51-0.05 (-3.21%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US1280583022
- CUSIP
- 128058302
Company
- Employees
- 21
- Headquarters
- Basking Ridge, United States
- Website
- https://www.lisata.com
- CEO
- Dr. David J. Mazzo B.A. (Hons), B.Sc. (Hons.), M.Sc., Ph.D.
Market
- Shares outstanding
- 9M
- Market cap
- $13.61M
Key dates
- Next earnings
- Nov 5, 2026
Highlights
No high and low reported for today's session.
- Market cap
- $13.61M
- EPS LTM
- -$1.62calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -0.93calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $100K-90.65%down year on year
- Net income
- -$14.62M+22.73%up year on year
- Gross margin
- 80%-4.99%down year on year
- Free cash flow
- -$12.32M+25.13%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.